Sintx Technologies EPS SINT
Diluted earnings per share by quarter and over the last twelve months, from 2013.
- Last 12 months, to Jun 30, 2026
- −$5.49
- Latest quarter, Q2 FY26
- −$0.75
- Fiscal year 2025
- −$6.24
Sintx Technologies' earnings per share was −$5.49 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was −$0.75.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$6.24 | n/a |
| FY2024 | −$33.49 | n/a |
| FY2023 | −$770.83 | n/a |
| FY2022 | −$10242.00 | n/a |
| FY2021 | −$7400.00 | n/a |
| FY2020 | −$41200.00 | n/a |
| FY2019 | −$151000.00 | n/a |
| FY2017 | −$1812000.00 | n/a |
| FY2016 | −$8916000.00 | n/a |
| FY2015 | −$51780000.00 | n/a |
| FY2014 | −$302400000.00 | n/a |
| FY2013 | −$1860840000.00 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | −$0.75 | n/a | −$5.49 | |
| Q1 FY26 | −$0.70 | n/a | −$5.65 | |
| Q4 FY25 | −$0.58 | n/a | −$6.24 | |
| Q3 FY25 | −$3.46 | n/a | −$6.92 | |
| Q2 FY25 | −$0.91 | n/a | −$10.42 | |
| Q1 FY25 | −$1.29 | n/a | −$13.12 | |
| Q4 FY24 | −$1.26 | n/a | −$33.49 | |
| Q3 FY24 | −$6.96 | n/a | −$138.55 | |
| Q2 FY24 | −$3.61 | n/a | −$292.80 | |
| Q1 FY24 | −$21.66 | n/a | −$444.49 | |
| Q4 FY23 | −$106.32 | n/a | −$770.83 | |
| Q3 FY23 | −$161.21 | n/a | −$4294.51 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Sintx Technologies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| SINTSintx Technologies | −$5.49 | |
| NEPHNephros | $0.16 | +33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| Peer median | $0.41 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Sintx Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.